Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Nonrulemaking

to determine whether Diazepam Injection USP,5 mg/mL,1-mL(ANDA No. 72-079), by Abbott labs, Inc., has been voluntarily lwithdrawn or withheld from sale for safety or efficacy reasons

🏛 Food and Drug Administration (FDA)FDA-2003-P-0341
Pharmaceutical PolicyProduct Safety & Recalls
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 2Notice 1Other 1
📄 Primary document
OtherApr 9, 2004
Federal Register Re: Letter from FDA CDER to PharmaForce, Inc.
No comment period
Open →